Ginsenoside 3β-O-Glc-DM (C3DM) suppressed glioma tumor growth by downregulating the EGFR/PI3K/AKT/mTOR signaling pathway and modulating the tumor microenvironment.

[1]  Xianglong Zhang,et al.  High-Fat Diet-Induced Fatty Liver Is Associated with Immunosuppressive Response during Sepsis in Mice , 2021, Oxidative medicine and cellular longevity.

[2]  Yan Liu,et al.  Ginsenoside Rh2 Inhibits Glycolysis through the STAT3/c-MYC Axis in Non-Small-Cell Lung Cancer , 2021, Journal of oncology.

[3]  N. Pećina-Šlaus,et al.  Integrative cBioPortal Analysis Revealed Molecular Mechanisms That Regulate EGFR-PI3K-AKT-mTOR Pathway in Diffuse Gliomas of the Brain , 2021, Cancers.

[4]  P. Wen,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications. , 2021, Neuro-oncology.

[5]  Yunfei Xu,et al.  WDR5 facilitates EMT and metastasis of cholangiocarcinoma by increasing HIF-1α accumulation in Myc-dependent and independent pathways. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Meilan Zhang,et al.  Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells , 2020, Frontiers in Pharmacology.

[7]  P. Wen,et al.  Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  R. Pérez-Tomás,et al.  Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment , 2020, Cancers.

[9]  D. Nam,et al.  Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts , 2020, Cancers.

[10]  Chen Yan,et al.  Ginsenoside 3β-O-Glc-DM (C3DM) enhances the antitumor activity of Taxol on Lewis lung cancer by targeting the interleukin-6/Jak2/STAT3 and interleukin-6/AKT signaling pathways , 2020 .

[11]  Liang Liu,et al.  Novel ginsenoside derivative 20(S)-Rh2E2 suppresses tumor growth and metastasis in vivo and in vitro via intervention of cancer cell energy metabolism , 2020, Cell Death & Disease.

[12]  Daidi Fan,et al.  Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. , 2020, Biochemical pharmacology.

[13]  H. Engelhard,et al.  Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma , 2020, Molecular Neurobiology.

[14]  Ruiping Zhang,et al.  Evaluation of the tumor-targeting efficiency and intratumor heterogeneity of anticancer drugs using quantitative mass spectrometry imaging , 2020, Theranostics.

[15]  Juxiang Chen,et al.  Immunotherapy for Malignant Glioma: Current Status and Future Directions. , 2020, Trends in pharmacological sciences.

[16]  Zev A. Binder,et al.  A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity , 2019, Cell.

[17]  J. Manzo-Merino,et al.  Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches , 2019, Front. Oncol..

[18]  S. Cai,et al.  Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer , 2019, Cancer Immunology Research.

[19]  J. Rabinowitz,et al.  The Tumor Metabolic Microenvironment: Lessons from Lactate. , 2019, Cancer research.

[20]  P. Zhu,et al.  Construction and optimization of microbial cell factories for sustainable production of bioactive dammarenediol-II glucosides , 2019, Green Chemistry.

[21]  Hyunggee Kim,et al.  Korean Red ginseng extract inhibits glioblastoma propagation by blocking the Wnt signaling pathway. , 2019, Journal of ethnopharmacology.

[22]  Xiaoying Wang,et al.  Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice. , 2019, International immunopharmacology.

[23]  L. Lynch,et al.  Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis , 2018, Cancer Immunology Research.

[24]  R. Verhaak,et al.  EGFR heterogeneity and implications for therapeutic intervention in glioblastoma , 2018, Neuro-oncology.

[25]  J. Cho,et al.  Functional role of ginseng-derived compounds in cancer , 2017, Journal of ginseng research.

[26]  Wenfeng Li,et al.  Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  C. Mancuso,et al.  Panax ginseng and Panax quinquefolius: From pharmacology to toxicology , 2017, Food and Chemical Toxicology.

[28]  D. Mcclements,et al.  Antitumor and immunomodulatory effects of ginsenoside Rh2 and its octyl ester derivative in H22 tumor-bearing mice , 2017 .

[29]  Marie Strickland,et al.  Metabolic Reprogramming in Glioma , 2017, Front. Cell Dev. Biol..

[30]  D. Quail,et al.  The Microenvironmental Landscape of Brain Tumors. , 2017, Cancer cell.

[31]  J. Wan,et al.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites , 2016, Evidence-based complementary and alternative medicine : eCAM.

[32]  M. Helmer-Citterich,et al.  c-MYC inhibition impairs hypoxia response in glioblastoma multiforme , 2016, Oncotarget.

[33]  Wei Zhang,et al.  Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma. , 2016, Radiology.

[34]  P. Nunn,et al.  The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor , 2015, Brain pathology.

[35]  Xu-Bin Wei,et al.  Ginsenoside Rh2-B1 stimulates cell proliferation and IFN-γ production by activating the p38 MAPK and ERK-dependent signaling pathways in CTLL-2 cells , 2014, Immunopharmacology and immunotoxicology.

[36]  Yongdong Feng,et al.  c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α. , 2013, Biochemical and biophysical research communications.

[37]  Alessia Ricupito,et al.  Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. , 2012, Cancer research.

[38]  I. Date,et al.  Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.

[39]  K. Podar,et al.  A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. , 2010, Cell cycle.

[40]  Forest M White,et al.  Oncogenic EGFR Signaling Networks in Glioma , 2009, Science Signaling.

[41]  yang-xin fu,et al.  Tumor-infiltrating T lymphocytes: friends or foes? , 2006, Laboratory Investigation.

[42]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.